Anticoagulant therapy is a well-established treatment for coronary thrombosis, pulmonary embolus, and other thrombotic or embolic episodes. The anticoagulant drugs used are usually those of the dicoumarol group. It is known that this group of drugs, " dindevan," "tromexan," "marcoumar," etc., depress the production of prothrombin and possibly to a greater extent that of factor VII (proconvertin). There is a variable time lag between dosage with the particular drug and its effect on the prothrombin and factor VII levels, It is this time lag and the method of estimating the level of the appropriate coagulation factors that have led to some difficulty in controlling the dosage of anticoagulant to be used in individual patients. The Quick one-stage method or some modification of this test has usually been the method of choice in this country. The two-stage method has also been used. The one-stage methods are sensitive to changes in factors V and VII levels and to a lesser extent of prothrombin; in the two-stage methods factor VII levels are ignored, and this latter fact is of importance, as it is known that factor VII is more markedly reduced than prothrombin. In 1951 Owren and Aas introduced the so-called P and P method (prothrombin and proconvertin) for the control of anticoagulant therapy. The method is sensitive to changes in prothrombin and factor VII levels, but insensitive to changes in factor V and fibrinogen. The method is basically a onestage one with the following modifications.
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(1) rhe plasma is diluted to increase sensitivity, and this dilution, of course, also minimizes the effect of any heparin in the patient's plasma. The advantages of this method have been stressed by Owren and Aas (1951) , by Astrup. Muillertz, and Hansen (1951) , by Miullertz and Storm (1954) (who maintained anticoagulant therapy during major surgery), by Astrup and Mullertz (1954) , and by Owren (1954) . The advantages claimed by these authors have been: (i) Greatly increased sensitivity over Quick's method, especially in the near normal range, making it very much easier to judge the initial hypocoagulability and subsequent dosage. (ii) There is less random variability than in the unmodified test because irrelevant factors are supplied in standard form. This is very important for the accurate stabilization of patients who will be receiving long-term anticoagulant therapy as out-patients. (iii) The method measures the combined effect of prothrombin and factor VII, both of which are important and which may be reduced to a different extent at different stages of treatment. (iv) In Quick's method the optimum calcium concentration may not be used, owing to variations in haematocrit values. This effect is minimized by the dilution. (v) The method is unaffected by small amounts of heparin in the patient's plasma. (vi) The use of a small amount of heparin in the anticoagulant used for the collection of the patient's blood sample enables accurate estimations to be made on blood samples which have been sent through the post. This is also advantageous in the long-term treatment of out-patients.
On the evidence of these observations it was decided that the method should be investigated in this department. Reagents
The method given here is the one used routinely in this department and differs slightly from Owren's original method. (a) Seitz filtration, when bovine plasma is passed through two grades of Seitz filter pad, containing 20% and 50% asbestos. The pads were manufactured by the Republic Seitz Filter Corp. of the U.S.A., the appropriate grades being G.P. for the first filtration and S3 for the second.
(b) Seitz filtration, as above except that Ford's " sterimats " were used. Grade F.C.B. was used for the first filtration and Grade SB for the second. (c) Adsorption was achieved with barium sulphate (see above). Patients being followed with Owren's method had daily estimations made with all three bovine plasma preparations. In all some 100 blood samples were tested, and no significant difference was found between the three preparations ( Fig. 1) occasionally M/20 has been selected. The effect of differing concentrations on the 100% and 50% levels of pooled normal plasma is usually quite small, whereas with the high dilutions of pooled normal plasma the effect will be more marked (Fig. 2) (Fig. 3) . Initially 10% and 20% dilutions were made daily, but this procedure gave rise to a good deal of unnecessary confusion because the clotting times of mixtures containing these high dilutions tended to be rather variable. The patient's plasma is always tested at the 1 in 10 dilution (100%) and the higher dilutions of the dilution curve are determined on multiple samples when random variability is reduced to a minimum. It therefore seemed best to adhere to the procedure used by the originators of the technique and test daily only the 1 in 10 and I in 20 dilutions of the normal plasma (100% and 50%) An example of the sort of differences that may be expected in changing from one set of reagents to another is shown in Table I . according to the results of Owren's method neither results of Owren's method show a slow but Linof the patients was ever established on an exactly mistakable downward trend. This finally becomes balancing dose. apparent on the unmodified method on the sevenDetailed examination indicates the main sources teenth day when the dose was reduced. The dose of difficulty. In Fig. 4 In Fig. 5 it is also clear that the failure to stabilize the dosage was mainly due to the very indefinite day-to-day trend of prothrombin times using the unmodified method. The balancing dose for this patient was probably of the order of 75 mg. daily.
The results obtained by any one-stage method reflect the dosage on the previous day with the addition of any drug cumulated from previous excessive doses. To reach a stabilizing dose it is therefore essential to apply an increasingly fine adjustment to the dose. Thus if 100 mg. doses are given on the first three days (Fig. 4) Detailed study of records such as these emphasizes the need for small dose adjustments. This is now possible since the introduction of the 10 mg. tablets of "dindevan." Using combinations of the 10 and 50 mg. tablets the dose may be adjusted to within 5 mg.
In the initial investigation of the method, patients receiving anticoagulant drugs had daily estimations made by both Quick's and Owren's method. About 1,500 blood samples from 63 patients were included in the survey. Almost invariably Owren's method showed the different trends in levels and hence dosage much sooner than did Quick's method. Also the day-to-day random variation was much smaller with Owren's method, making the trends much more obvious. The large random variation of Quick's method tended to mask rising or falling levels.
Owren's method has now been used for all anticoagulant work in this hospital group for 20 months. During this time nearly 12,000 estimations have been made, and the method has proved eminently satisfactory. The small random variation makes the method very suitable for outpatients receiving long-term therapy. It is also an advantage in that blood specimens can be sent by post with little effect on the result, making it possible for general practitioners to collect the samples in districts at some distance from the hospital. Summary A description is -iven of the P and P (prothrombin and proconvertin) method of Owren as used routinely in this department for the control of anticoagulant therapy. The method has been found to be more sensitive and subject to less random variation than Quick's one-stage method and to be particularly suitable for the control of long-term anticoagulant therapy.
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